As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, today announced a licensing and collaboration ...

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

My dentist explained that using a water flosser lessens the amount of fine motor movement necessary to get in between teeth.

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

Real-time index price for Nasdaq 100 Technology Index (NDXT), along with buy or sell indicators, analysis, charts, historical ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

AstraZeneca continues to advance its ambition to revolutionise cancer care with pivotal data presented for lung, gastrointestinal (GI), and breast cancers at the recent ESMO Asia Congress 2024. With a ...

Eighty percent of doctors in a Medscape survey answered no when asked, “Is enough known about obesity meds’ risk to ...